StockTipsArenaBeta

SELL Cipla Ltd. — Morgan Stanley

SELLCipla Ltd.
Cipla share price target & all analyst calls

byMorgan StanleyHorizon: NA (inferred 1 year)24 Jul 2026via NDTV Profit (Live)

Entry₹1,390.1Inferred
Target₹1,218
Total upside +12.38%
Stop lossNot given
CMP₹1,3382d ago
Active+3.75%+8.97%upside left 9 mo left
Follow Morgan Stanley for new calls(97% target hit, 33 closed calls)Get alertsWatch CIPLA for new buy/sell callsGet alertsSee 16 other Long-term calls on CIPLASee 274 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 10:47 pm IST
20 supporting23 neutral15 opposing
Supports the SELL call (20)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·23 Oct · 2d ago

Cipla Disappointed By Maharashtra FDA Action, Says Pune Warehouse Complies With Protocols

NewsNdtv-Profit·2 Oct · 3w ago

(opens in new tab)

Maharashtra FDA Cancels Cipla Pune Warehouse Drug Licences Over Violations

NewsNdtv-Profit·2 Oct · 3w ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·24 Jul · 3mo ago

Neutral / worth noting (23)

Q2 FY27 results scheduled — board meets 27 Oct 2026

BSE · Board Meeting·In 1 day

(opens in new tab)

These four pharma stocks will be reacting to important news updates today

NewsCnbc-Tv18·5 Oct · 3w ago

(opens in new tab)
Weighs against the SELL call (15)

8 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·28 Sept · 4w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Cipla

All analyst calls on Cipla

More from Morgan Stanley

Every call and its outcome